Bellerophon Therapeutics Inc., of Hampton, N.J., closed its IPO Feb. 19 after raising $60 million through the sale of 5 million shares priced at $12 each. Company shares, which began trading on Nasdaq under the ticker BLPH, closed at $9.42 on Friday.